BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22683934)

  • 1. Inhibition of GSK-3β reverses the pro-apoptotic effect of proadifen (SKF-525A) in HT-29 colon adenocarcinoma cells.
    Jendželovský R; Koval J; Mikeš J; Papčová Z; Plšíková J; Fedoročko P
    Toxicol In Vitro; 2012 Sep; 26(6):775-82. PubMed ID: 22683934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression.
    Ban JO; Oh JH; Son SM; Won D; Song HS; Han SB; Moon DC; Kang KW; Song MJ; Hong JT
    Cancer Biol Ther; 2011 Aug; 12(4):288-96. PubMed ID: 21613824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.
    Yoshino Y; Ishioka C
    Sci Rep; 2015 Aug; 5():13249. PubMed ID: 26292722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone.
    Ban JO; Kwak DH; Oh JH; Park EJ; Cho MC; Song HS; Song MJ; Han SB; Moon DC; Kang KW; Hong JT
    Chem Biol Interact; 2010 Oct; 188(1):75-85. PubMed ID: 20540935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth.
    Carter YM; Kunnimalaiyaan S; Chen H; Gamblin TC; Kunnimalaiyaan M
    Cancer Biol Ther; 2014 May; 15(5):510-5. PubMed ID: 24521712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression.
    Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
    HPB (Oxford); 2015 Sep; 17(9):770-6. PubMed ID: 26147011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells.
    Zhou YX; Shi Z; Singh P; Yin H; Yu YN; Li L; Walsh MP; Gui Y; Zheng XL
    J Cell Physiol; 2016 Feb; 231(2):393-402. PubMed ID: 26129946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
    Ougolkov AV; Fernandez-Zapico ME; Bilim VN; Smyrk TC; Chari ST; Billadeau DD
    Clin Cancer Res; 2006 Sep; 12(17):5074-81. PubMed ID: 16951223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3 is involved in the regulation of the cell cycle in cerebellar granule cells.
    Yeste-Velasco M; Folch J; Trullàs R; Abad MA; Enguita M; Pallàs M; Camins A
    Neuropharmacology; 2007 Aug; 53(2):295-307. PubMed ID: 17612578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursolic acid from Oldenlandia diffusa induces apoptosis via activation of caspases and phosphorylation of glycogen synthase kinase 3 beta in SK-OV-3 ovarian cancer cells.
    Song YH; Jeong SJ; Kwon HY; Kim B; Kim SH; Yoo DY
    Biol Pharm Bull; 2012; 35(7):1022-8. PubMed ID: 22791147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.
    Menon B; Johnson JN; Ross RS; Singh M; Singh K
    J Mol Cell Cardiol; 2007 Mar; 42(3):653-61. PubMed ID: 17292911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of GSK-3beta enhances reovirus-induced apoptosis in colon cancer cells.
    Min HJ; Koh SS; Cho IR; Srisuttee R; Park EH; Jhun BH; Kim YG; Oh S; Kwak JE; Johnston RN; Chung YH
    Int J Oncol; 2009 Sep; 35(3):617-24. PubMed ID: 19639182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3β and ΔNp63.
    Chow SE; Chang YL; Chuang SF; Wang JS
    Cancer Chemother Pharmacol; 2011 Oct; 68(4):835-45. PubMed ID: 21207227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of N-alkyl or aryl substituted isoindigo derivatives as potential dual cyclin-dependent kinase 2 (CDK2)/glycogen synthase kinase 3β (GSK-3β) phosphorylation inhibitors.
    Zhao P; Li Y; Gao G; Wang S; Yan Y; Zhan X; Liu Z; Mao Z; Chen S; Wang L
    Eur J Med Chem; 2014 Oct; 86():165-74. PubMed ID: 25151579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells.
    Ougolkov AV; Fernandez-Zapico ME; Savoy DN; Urrutia RA; Billadeau DD
    Cancer Res; 2005 Mar; 65(6):2076-81. PubMed ID: 15781615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuroprotective effect of the GSK-3β inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice.
    Ahn SW; Kim JE; Park KS; Choi WJ; Hong YH; Kim SM; Kim SH; Lee KW; Sung JJ
    J Neurol Sci; 2012 Sep; 320(1-2):1-5. PubMed ID: 22698482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of BCRP and anti-apoptotic proteins by proadifen (SKF-525A) is responsible for the enhanced mitoxantrone accumulation and toxicity in mitoxantrone-resistant human promyelocytic leukemia cells.
    Hiľovská L; Jendželovský R; Jendželovská Z; Kovaľ J; Fedoročko P
    Int J Oncol; 2015 Oct; 47(4):1572-84. PubMed ID: 26252082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glycogen synthase kinase-3β/nuclear factor-kappa B pathway is involved in cinobufagin-induced apoptosis in cultured osteosarcoma cells.
    Yin JQ; Wen L; Wu LC; Gao ZH; Huang G; Wang J; Zou CY; Tan PX; Yong BC; Jia Q; Shen JN
    Toxicol Lett; 2013 Apr; 218(2):129-36. PubMed ID: 23164673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3β and CDK1.
    Mayes PA; Dolloff NG; Daniel CJ; Liu JJ; Hart LS; Kuribayashi K; Allen JE; Jee DI; Dorsey JF; Liu YY; Dicker DT; Brown JM; Furth EE; Klein PS; Sears RC; El-Deiry WS
    Cancer Res; 2011 Aug; 71(15):5265-75. PubMed ID: 21646472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetramethylpyrazine inhibits the proliferation of acute lymphocytic leukemia cell lines via decrease in GSK-3β.
    Wang XJ; Xu YH; Yang GC; Chen HX; Zhang P
    Oncol Rep; 2015 May; 33(5):2368-74. PubMed ID: 25812605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.